About this trial
Detect the effect of different treatment modalities of tubal ectopic pregnancy on ovarian reserve
Eligibility criteria
Qualifiers
The study will include patients aged 18-44 years with known diagnosis or suspicion of diagnosis of tubal ectopic pregnancy (abnormal doubling rates of their b-HCG levels as well as ultrasonographically identified or unidentified gestational sacs outside the uterus)
Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery
Disqualifiers
The use of hormonal contraceptives within two months of enrolment
If other surgery was conducted at the time of salpingectomy.
If a woman was pregnant at follow up visit for AMH measurement
History of previous surgeries of fallopian tubes and/or ovaries
Trial design
Treatments tested in this trial
- Amh hormone
Treatment groups
6
Treatment groupsSee each treatment group below.